These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Von hippel-lindau disease and erythrocytosis. Capodimonti S; Teofili L; Martini M; Cenci T; Iachininoto MG; Nuzzolo ER; Bianchi M; Murdolo M; Leone G; Larocca LM J Clin Oncol; 2012 May; 30(13):e137-9. PubMed ID: 22393103 [No Abstract] [Full Text] [Related]
30. [A family of von Hippel-Lindau disease with renal cell carcinoma--case report and review of the literature]. Ito F; Uda M; Toma H Hinyokika Kiyo; 1991 Feb; 37(2):157-62. PubMed ID: 2048495 [TBL] [Abstract][Full Text] [Related]
31. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]. Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987 [TBL] [Abstract][Full Text] [Related]
32. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. Jimenez C; Cabanillas ME; Santarpia L; Jonasch E; Kyle KL; Lano EA; Matin SF; Nunez RF; Perrier ND; Phan A; Rich TA; Shah B; Williams MD; Waguespack SG J Clin Endocrinol Metab; 2009 Feb; 94(2):386-91. PubMed ID: 19017755 [TBL] [Abstract][Full Text] [Related]
33. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma. Rich TA; Jonasch E; Matin S; Waguespack SG; Gombos DS; Santarpia L; Stolle C; Jimenez C Cancer Invest; 2008 Jul; 26(6):642-6. PubMed ID: 18584357 [TBL] [Abstract][Full Text] [Related]
34. Benefits of screening in von Hippel-Lindau disease--comparison of morbidity associated with initial tumours in affected parents and children. Priesemann M; Davies KM; Perry LA; Drake WM; Chew SL; Monson JP; Savage MO; Johnston LB Horm Res; 2006; 66(1):1-5. PubMed ID: 16651847 [TBL] [Abstract][Full Text] [Related]
35. Renal lesions and pheochromocytoma in von Hippel-Lindau disease. Richard S; Chauveau D; Chrétien Y; Beigelman C; Denys A; Fendler JP; Fromont G; Paraf F; Hélénon O; Nizard S Adv Nephrol Necker Hosp; 1994; 23():1-27. PubMed ID: 8154348 [No Abstract] [Full Text] [Related]
36. Pheochromocytoma and von Hippel-Lindau's disease. Lowden BA; Harris GS Can J Ophthalmol; 1976 Oct; 11(4):282-9. PubMed ID: 974851 [TBL] [Abstract][Full Text] [Related]
37. A forme fruste of von Hippel-Lindau disease: a combination of adrenal pheochromocytoma and ipsilateral renal cell carcinoma--a case report. Horbach JM; Brenninkmeyer SJ; van de Velde CJ; Kruseman AC Surgery; 1989 Mar; 105(3):436-41. PubMed ID: 2646747 [TBL] [Abstract][Full Text] [Related]
39. Bilateral pheochromocytomas in a child who had hemihypertrophy and alteration in the VHL gene. Amini Z; Babovic-Vuksanovic D; Lteif A J Pediatr Endocrinol Metab; 2013; 26(3-4):369-72. PubMed ID: 23327821 [TBL] [Abstract][Full Text] [Related]
40. Spectrum of magnetic resonance imaging findings in pancreatic and other abdominal manifestations of Von Hippel-Lindau disease in a series of 23 patients: a pictorial review. Graziani R; Mautone S; Vigo M; Manfredi R; Opocher G; Falconi M JOP; 2014 Jan; 15(1):1-18. PubMed ID: 24413778 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]